FEB 12, 2020 6:52 PM PST

Diabetic Drug Increasces Risk of Heart Complications

WRITTEN BY: Nouran Amin

A drug by the name of ‘rosiglitazone’ used to treat type 2 diabetes was found to be associated with increased risk of heart problems, especially heart failure. Findings were based on a comprehensive evaluation of the cardiovascular risk from rosiglitazone use.

Rosiglitazone belongs to a class of drugs known as thiazolidinediones that help target blood sugar levels in patients with type 2 diabetes, however, it can also increase the risk of heart complications. As a result, Rosiglitazone use was suspended in Europe and holds previous restrictions in the United States.

Researchers stated: "Our study highlights the need for independent evidence assessment to promote transparency and ensure confidence in approved therapeutics, and postmarket surveillance that tracks known and unknown risks and benefits."

Learn more:

But, since 2007, studies reported conflicting findings about whether rosiglitazone does lead to risky heart complications. These studies did not access raw data from patients and mostly were based on summary level data that was not to the highest reliability. The drug maker of rosiglitazone--GlaxoSmithKline (GSK)--has placed effort to make patient data available for investigators and thus prompted researchers to re-analyze uncertainty about the role of the drug in cardiovascular risk.

"Our study suggests that when evaluating drug safety and performing meta-analyses focused on safety, IPD might be necessary to accurately classify all adverse events," noted the researchers. "By including these data in research, patients, clinicians, and researchers would be able to make more informed decisions about the safety of interventions."

Source: Science Daily

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
AUG 04, 2020
Drug Discovery & Development
Erectile Dysfunction Drug Cures Critical COVID-19 Patients
AUG 04, 2020
Erectile Dysfunction Drug Cures Critical COVID-19 Patients
Critically ill patients who received COVID-19 drug candidate aviptadil (RLF-100) were able to make a rapid recovery from ...
AUG 11, 2020
Drug Discovery & Development
FDA Approves New Opioid for Short-Term Use
AUG 11, 2020
FDA Approves New Opioid for Short-Term Use
The US Food and Drug Administration has announced the approval of Olinvyk (oliceridine), a new opioid that can help mana ...
AUG 11, 2020
Drug Discovery & Development
Scientists Discover Key Gene Behind Antibiotic Resistance
AUG 11, 2020
Scientists Discover Key Gene Behind Antibiotic Resistance
Scientists from Oxford University have shown that a single gene can make some strains of Staphylococcus aureus (the bact ...
AUG 19, 2020
Cancer
Testing the Toxicity of CDK Inhibitors and Radiotherapy
AUG 19, 2020
Testing the Toxicity of CDK Inhibitors and Radiotherapy
Drug targets often focus on one thing, inhibiting or activating some critical function in a cell. Cancer drugs are no di ...
AUG 18, 2020
Drug Discovery & Development
Psychedelic Medicine Reduces Inflammation from Asthma
AUG 18, 2020
Psychedelic Medicine Reduces Inflammation from Asthma
Aside from mental health applications, psychedelics are also known for their antiinflammatory effects. And now, a compan ...
SEP 07, 2020
Microbiology
How THC Can Help Relieve a Respiratory Disorder
SEP 07, 2020
How THC Can Help Relieve a Respiratory Disorder
Acute respiratory distress syndrome (ARDS) occurs when fluid builds up in the sacs in the lungs that hold air, and the l ...
Loading Comments...